Publication

Phase II explorative trial to prospectively investigate predictive molecular biomarkers for efficacy of panitumumab (P) in platinum-pretreated head and neck squamous cell cancer (HNSCC)

Conference Paper/Poster - Sep 29, 2015

Siano Marco